Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Gammagard

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



Living With Dementia

treatment of alzheimer's disease1 - hearing loss1 - spect1 - regular caffeine consumption1 - medium spiny neurons1 - reverse cholesterol transport1 - emotional lability1 - disorientation3 - parkinson's patients5 - slowed movement1 - quantitative structural neuroimaging1 - hospice2 - dementia care program1 - cognitive reserve1 - glucose metabolism2 - cortical atrophy1 - stress management1 - dementia of the alzheimer type1 - wernicke's encephalopathy4 - alzheimer's signs1 - abeta1 - impaired-memory disorder1 - mmse1 - huntington’s disease2 - ophthalmoplegia4 - sleep-disordered breathing1 - hearing1 - cognitive impairment10 - virtual reality1 - alzheimer brain1 -